However, regression analyses suggest a stronger correlation between ezrin levels and NSC sensitivity compared with radixin in breast cancer cells (Fig. 3) and that breast cancer cells may be more dependent on ezrin function over other ERMs. Here, EZR is linked to breast carcinoma.